[1]
|
Rudolph, A., Chang-Claude, J. and Schmidt, M. (2016) Gene-Environment Interaction and Risk of Breast Cancer. British Journal of Cancer, 114, 125-133. https://doi.org/10.1038/bjc.2015.439
|
[2]
|
Rajagopala, S., Vashee, S., Oldfield, L.M., Suzuki, Y., Venter, J.C., Telenti, A., Nelson, K.E., et al. (2017) The Human Microbiome and Cancer. Cancer Prevention Research, 10, 226-234.
https://doi.org/10.1158/1940-6207.CAPR-16-0249
|
[3]
|
Jia, W., Xie, G. and Jia, W. (2018) Bile Acid-Microbiota Crosstalk in Gastrointestinal Inflammation and Carcinogenesis. Nature Reviews. Gastroenterology & Hepatology, 15, 111-128. https://doi.org/10.1038/nrgastro.2017.119
|
[4]
|
Armstrong, H., Bording-Jorgensen, M., Dijk, S. and Wine, E. (2018) The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It. Cancers, 10, Article No. 83. https://doi.org/10.3390/cancers10030083
|
[5]
|
Urbaniak, C., Cummins, J., Brackstone, M., Macklaim, J.M., Gloor, G.B., Baban, C.K., et al. (2014) Microbiota of Human Breast Tissue. Applied and Environmental Microbiology, 80, 3007-3014.
https://doi.org/10.1128/AEM.00242-14
|
[6]
|
Thyagarajan, S., Zhang, Y., Thapa, S., Allen, M.S., Phillips, N., Chaudhary, P., et al. (2020) Comparative Analysis of Racial Differences in Breast Tumor Microbiome. Scientific Reports, 10, Article No. 14116.
https://doi.org/10.1038/s41598-020-71102-x
|
[7]
|
Hieken, T., Chen, J., Hoskin, T.L., Walther-Antonio, M., Johnson, S., Ramaker, S., et al. (2016) The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Scientific Reports, 6, Article No. 30751.
https://doi.org/10.1038/srep30751
|
[8]
|
Chiba, A., Bawaneh, A., Velazquez, C., Clear, K.Y.J., Wilson, A.S., Howard-McNatt, M., et al. (2020) Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis. Molecular Cancer Research, 18, 130-139. https://doi.org/10.1158/1541-7786.MCR-19-0451
|
[9]
|
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L.T., et al. (2020) The Human Tumor Microbiome Is Composed of Tumor Type-Specific Intracellular Bacteria. Science, 368, 973-980.
https://doi.org/10.1126/science.aay9189
|
[10]
|
Thompson, K., Ingle, J.N., Tang, X., Chia, N., Jeraldo, P.R., Walther-Antonio, M.R., et al. (2017) A Comprehensive Analysis of Breast Cancer Microbiota and Host Gene Expression. PLoS ONE, 12, e0188873.
https://doi.org/10.1371/journal.pone.0188873
|
[11]
|
Wang, H., Altemus, J., Niazi, F., Green, H., Calhoun, B.C., Sturgis, C., et al. (2017) Breast Tissue, Oral and Urinary Microbiomes in Breast Cancer. Oncotarget, 8, 88122-88138. https://doi.org/10.18632/oncotarget.21490
|
[12]
|
Smith, A., Pierre, J.F., Makowski, L., Tolley, E., Lyn-Cook, B., Lu, L., et al. (2019) Distinct Microbial Communities That Differ by Race, Stage, or Breast-Tumor Subtype in Breast Tissues of Non-Hispanic Black and Non-Hispanic White Women. Scientific Reports, 9, Article No. 11940. https://doi.org/10.1038/s41598-019-48348-1
|
[13]
|
Urbaniak, C., Gloor, G.B., Brackstone, M., Scott, L., Tangney, M. and Reid, G. (2016) The Microbiota of Breast Tissue and Its Association with Breast Cancer. Applied and Environmental Microbiology, 82, 5039-5048.
https://doi.org/10.1128/AEM.01235-16
|
[14]
|
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H.M., Nomburg, J., et al. (2020) Mutational Signature in Colorectal Cancer Caused by Genotoxic Pks+ E. coli. Nature, 580, 269-273.
https://doi.org/10.1038/s41586-020-2080-8
|
[15]
|
Meng, S., Chen, B., Yang, J., Wang, J., Zhu, D., Meng, Q., et al. (2018) Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in Situ Tissue Microbiomes for Promoting Malignancy. Frontiers in Oncology, 8, Article No. 318. https://doi.org/10.3389/fonc.2018.00318
|
[16]
|
Costantini, L., Magno, S., Albanese, D., Donati, C., Molinari, R., Filippone, A., et al. (2018) Characterization of Human Breast Tissue Microbiota from Core Needle Biopsies through the Analysis of Multi Hypervariable 16S-rRNA Gene Regions. Scientific Reports, 8, Article No. 16893. https://doi.org/10.1038/s41598-018-35329-z
|
[17]
|
Hunt, K., Foster, J.A., Forney, L.J., Schütte, U.M.E., Beck, D.L., Abdo, Z., et al. (2011) Characterization of the Diversity and Temporal Stability of Bacterial Communities in Human Milk. PLoS ONE, 6, e21313.
https://doi.org/10.1371/journal.pone.0021313
|
[18]
|
Martín, R., Jiménez, E., Heilig, H., Fernández, L., Marín, M.L., Zoetendal, E.G., et al. (2009) Isolation of Bifidobacteria from Breast Milk and Assessment of the Bifidobacterial Population by PCR-Denaturing Gradient Gel Electrophoresis and Quantitative Real-Time PCR. Applied and Environmental Microbiology, 75, 965-969.
https://doi.org/10.1128/AEM.02063-08
|
[19]
|
Bouladoux, N., Hall, J.A., Grainger, J.R., dos Santos, L.M., Kann, M.G., Nagarajan, V., et al. (2012) Regulatory Role of Suppressive Motifs from Commensal DNA. Mucosal Immunology, 5, 623-634. https://doi.org/10.1038/mi.2012.36
|
[20]
|
Chan, A., Bashir, M., Rivas, M.N., Duvall, K., Sieling, P.A., Pieber, T.R., et al. (2016) Characterization of the Microbiome of Nipple Aspirate Fluid of Breast Cancer Survivors. Scientific Reports, 6, Article No. 28061.
https://doi.org/10.1038/srep28061
|
[21]
|
Mowat, A. and Agace, W. (2014) Regional Specialization within the Intestinal Immune System. Nature Reviews. Immunology, 14, 667-685. https://doi.org/10.1038/nri3738
|
[22]
|
Shapira, I., Sultan, K., Lee, A. and Taioli, E. (2013) Evolving Concepts: How Diet and the Intestinal Microbiome Act as Modulators of Breast Malignancy. International Scholarly Research Notices, 2013, Article ID: 693920.
https://doi.org/10.1155/2013/693920
|
[23]
|
Vétizou, M., Pitt, J.M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., et al. (2015) Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota. Science, 350, 1079-1084. https://doi.org/10.1126/science.aad1329
|
[24]
|
Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., et al. (2015) Commensal Bifidobacterium Promotes Antitumor Immunity and Facilitates Anti-PD-L1 Efficacy. Science, 350, 1084-1089.
https://doi.org/10.1126/science.aac4255
|
[25]
|
Plummer, M., van Doorn, L.J., Franceschi, S., Kleter, B., Canzian, F., Vivas, J., et al. (2007) Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions. Journal of the National Cancer Institute, 99, 1328-1334.
https://doi.org/10.1093/jnci/djm120
|
[26]
|
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E. and Rodriguez Yoldi, M. (2017) Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. International Journal of Molecular Sciences, 18, Article No. 197. https://doi.org/10.3390/ijms18010197
|
[27]
|
Zhu, J., Liao, M., Yao, Z., Liang, W., Li, Q., Liu, J., et al. (2018) Breast Cancer in Postmenopausal Women Is Associated with an Altered Gut Metagenome. Microbiome, 6, Article No. 136. https://doi.org/10.1186/s40168-018-0515-3
|
[28]
|
Goedert, J., Jones, G., Hua, X., Xu, X., Yu, G., Flores, R., et al. (2015) Investigation of the Association between the Fecal Microbiota and Breast Cancer in Postmenopausal Women: A Population-Based Case-Control Pilot Study. Journal of the National Cancer Institute, 107, Articel No. djv147. https://doi.org/10.1093/jnci/djv147
|
[29]
|
Wu, A., Tseng, C., Vigen, C., Yu, Y., Cozen, W., Garcia, A.A., et al. (2020) Gut Microbiome Associations with Breast Cancer Risk Factors and Tumor Characteristics: A Pilot Study. Breast Cancer Research and Treatment, 182, 451-463.
https://doi.org/10.1007/s10549-020-05702-6
|
[30]
|
Paulsen, J., Ptacek, T.S., Carter, S.J., Liu, N., Kumar, R., Hyndman, L., et al. (2017) Gut Microbiota Composition Associated with Alterations in Cardiorespiratory Fitness and Psychosocial Outcomes among Breast Cancer Survivors. Supportive Care in Cancer, 25, 1563-1570. https://doi.org/10.1007/s00520-016-3568-5
|
[31]
|
Singh, R., Chang, H.W., Yan, D., Lee, K.M., Ucmak, D., Wong, K., et al. (2017) Influence of Diet on the Gut Microbiome and Implications for Human Health. Journal of Translational Medicine, 15, Article No. 73.
https://doi.org/10.1186/s12967-017-1175-y
|
[32]
|
Xiao, Y., Xia, J., Li, L., Ke, Y., Cheng, J., Xie, Y., et al. (2019) Associations between Dietary Patterns and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Breast Cancer Research, 21, Article No. 16. https://doi.org/10.1186/s13058-019-1096-1
|
[33]
|
Saxe, G., Rock, C., Wicha, M. and Schottenfeld, D. (1999) Diet and Risk for Breast Cancer Recurrence and Survival. Breast Cancer Research and Treatment, 53, 241-253. https://doi.org/10.1023/A:1006190820231
|
[34]
|
Shastri, A., Saleh, A., Savage, J.E., DeAngelis, T., Camphausen, K. and Simone, N.L. (2020) Dietary Alterations Modulate the MicroRNA 29/30 and IGF-1/AKT Signaling Axis in Breast Cancer Liver Metastasis. Nutrition & Metabolism, 17, Article No. 23. https://doi.org/10.1186/s12986-020-00437-z
|
[35]
|
Picon-Ruiz, M., Morata-Tarifa, C., Valle-Goffin, J., Friedman, E. and Slingerland, J. (2017) Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention. CA: A Cancer Journal for Clinicians, 67, 378-397. https://doi.org/10.3322/caac.21405
|
[36]
|
Steiner, J., Davis, J., McClellan, J., Enos, R., Carson, J., Fayad, R., et al. (2014) Dose-Dependent Benefits of Quercetin on Tumorigenesis in the C3(1)/SV40Tag Transgenic Mouse Model of Breast Cancer. Cancer Biology & Therapy, 15, 1456-1467. https://doi.org/10.4161/15384047.2014.955444
|
[37]
|
Castillo-Pichardo, L., Martínez-Montemayor, M.M., Martínez, J.E., Wall, K.M., Cubano, L.A. and Dharmawardhane, S. (2009) Inhibition of Mammary Tumor Growth and Metastases to Bone and Liver by Dietary Grape Polyphenols. Clinical & Experimental Metastasis, 26, 505-516. https://doi.org/10.1007/s10585-009-9250-2
|
[38]
|
Bhatt, A., Redinbo, M. and Bultman, S. (2017) The Role of the Microbiome in Cancer Development and Therapy. CA: A Cancer Journal for Clinicians, 67, 326-344. https://doi.org/10.3322/caac.21398
|
[39]
|
Jakobsson, H., Jernberg, C., Andersson, A.F., Sjölund-Karlsson, M., Jansson, J.K. and Engstrand, L. (2010) Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome. PLoS ONE, 5, e9836. https://doi.org/10.1371/journal.pone.0009836
|
[40]
|
Hassan, Z., Mustafa, S., Rahim, R. and Isa, N. (2016) Anti-Breast Cancer Effects of Live, Heat-Killed and Cytoplasmic Fractions of Enterococcus faecalis and Staphylococcus hominis Isolated from Human Breast Milk. In Vitro Cellular & Developmental Biology: Animal, 52, 337-348. https://doi.org/10.1007/s11626-015-9978-8
|
[41]
|
Lakritz, J., Poutahidis, T., Levkovich, T., Varian, B.J., Ibrahim, Y.M., Chatzigiagkos, A., et al. (2014) Beneficial Bacteria Stimulate Host Immune Cells to Counteract Dietary and Genetic Predisposition to Mammary Cancer in Mice. International Journal of Cancer, 135, 529-540. https://doi.org/10.1002/ijc.28702
|
[42]
|
Siewert, C., Haas, H., Cornet, V., Nogueira, S.S., Nawroth, T., Uebbing, L., et al. (2020) Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA. Cells, 9, Article No. 2034.
https://doi.org/10.3390/cells9092034
|
[43]
|
Guan, X., Ma, F., Sun, X., Li, C., Li, L., Liang, F., et al. (2020) Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage. Frontiers in Oncology, 10, Article No. 902. https://doi.org/10.3389/fonc.2020.00902
|
[44]
|
Tsang, J. and Tse, G. (2020) Molecular Classification of Breast Cancer. Advances in Anatomic Pathology, 27, 27-35.
https://doi.org/10.1097/PAP.0000000000000232
|
[45]
|
Dickson, R., Erb-Downward, J., Martinez, F. and Huffnagle, G. (2016) The Microbiome and the Respiratory Tract. Annual Review of Physiology, 78, 481-504. https://doi.org/10.1146/annurev-physiol-021115-105238
|
[46]
|
Lehouritis, P., Cummins, J., Stanton, M., Murphy, C.T., McCarthy, F.O., Reid, G., et al. (2015) Local Bacteria Affect the Efficacy of Chemotherapeutic Drugs. Scientific Reports, 5, Article No. 14554. https://doi.org/10.1038/srep14554
|
[47]
|
Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., et al. (2013) Commensal Bacteria Control Cancer Response to therapy by Modulating the Tumor Microenvironment. Science, 342, 967-970.
https://doi.org/10.1126/science.1240527
|
[48]
|
McGee, H., Jiang, D., Soto-Pantoja, D.R., Nevler, A., Giaccia, A.J., et al. (2019) Targeting the Tumor Microenvironment in Radiation Oncology: Proceedings from the 2018 ASTRO-AACR Research Workshop. Clinical Cancer Research, 25, 2969-2974. https://doi.org/10.1158/1078-0432.CCR-18-3781
|
[49]
|
Rahal, O., Wolfe, A.R., Mandal, P.K., Larson, R., Tin, S., Jimenez, C., et al. (2018) Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. International Journal of Radiation Oncology, Biology, Physics, 100, 1034-1043. https://doi.org/10.1016/j.ijrobp.2017.11.043
|
[50]
|
Hill, A., Hanson, M., Bogle, M. and Duvic, M. (2004) Severe Radiation Dermatitis Is Related to Staphylococcus aureus. American Journal of Clinical Oncology, 27, 361-363. https://doi.org/10.1097/01.COC.0000071418.12121.C2
|
[51]
|
Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103.
https://doi.org/10.1126/science.aan4236
|
[52]
|
Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillère, R., et al. (2018) Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy against Epithelial Tumors. Science, 359, 91-97.
https://doi.org/10.1126/science.aan3706
|
[53]
|
Planes-Laine, G., Rochigneux, P., Bertucci, F., Chrétien, A.S., Viens, P., Sabatier, R., et al. (2019) PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review. Cancers, 11, Article No. 1033. https://doi.org/10.3390/cancers11071033
|
[54]
|
Plaza-Díaz, J., Álvarez-Mercado, A.I., Ruiz-Marín, C.M., Reina-Pérez, I., Pérez-Alonso, A.J., Sánchez-Andujar, M.B., et al. (2019) Association of Breast and Gut Microbiota Dysbiosis and the Risk of Breast Cancer: A Case-Control Clinical Study. BMC Cancer, 19, Article No. 495. https://doi.org/10.1186/s12885-019-5660-y
|